Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[The level of evidence for the use of biomarkers in the early detection of prostate cancer].
Lamy PJ, Gauchez AS, Salomon L, Haugh M, Ceraline J, Fulla Y, Georges A, Larré S, Loric S, Luporsi E, Martin PM, Mazerolles C, Molinié V, Mongiat-Artus P, Piffret J, Thuillier F, Perrin P, Rebillard X; Groupe de biologie de la prostate. Lamy PJ, et al. Among authors: mazerolles c. Ann Biol Clin (Paris). 2016 Mar-Apr;74(2):227-32. doi: 10.1684/abc.2016.1128. Ann Biol Clin (Paris). 2016. PMID: 27029727 Free article. Review. French.
[The uropathological standardized reports].
Molinié V, de Fromont M, Lesourd A, Mazerolles C, Fromont G, Soulié M, Mottet N, Irani J, Méjean A, Rebillard X, Davin JL. Molinié V, et al. Among authors: mazerolles c. Ann Pathol. 2008 Oct;28(5):429-58. doi: 10.1016/j.annpat.2008.06.035. Ann Pathol. 2008. PMID: 19086152 French. No abstract available.
[Migration of pathological stage after radical prostatectomy to higher risk tumors of relapse: comparative two-center study between 2005 and 2010].
Beauval JB, Roumiguié M, Doumerc N, Thoulouzan M, Huyghe E, Allory Y, Mazerolles C, de la Taille A, Malavaud B, Rischmann P, Soulié M, Salomon L. Beauval JB, et al. Among authors: mazerolles c. Prog Urol. 2012 Dec;22(16):1015-20. doi: 10.1016/j.purol.2012.07.013. Epub 2012 Sep 3. Prog Urol. 2012. PMID: 23178098 French.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators. Schröder FH, et al. Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6. Lancet. 2014. PMID: 25108889 Free PMC article. Clinical Trial.
Prostate-cancer mortality at 11 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Páez A, Määttänen L, Bangma CH, Aus G, Carlsson S, Villers A, Rebillard X, van der Kwast T, Kujala PM, Blijenberg BG, Stenman UH, Huber A, Taari K, Hakama M, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2012 Mar 15;366(11):981-90. doi: 10.1056/NEJMoa1113135. N Engl J Med. 2012. PMID: 22417251 Free PMC article. Clinical Trial.
Screening and prostate-cancer mortality in a randomized European study.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.
Mannose-6-phosphate receptor: a target for theranostics of prostate cancer.
Vaillant O, El Cheikh K, Warther D, Brevet D, Maynadier M, Bouffard E, Salgues F, Jeanjean A, Puche P, Mazerolles C, Maillard P, Mongin O, Blanchard-Desce M, Raehm L, Rébillard X, Durand JO, Gary-Bobo M, Morère A, Garcia M. Vaillant O, et al. Among authors: mazerolles c. Angew Chem Int Ed Engl. 2015 May 11;54(20):5952-6. doi: 10.1002/anie.201500286. Epub 2015 Mar 20. Angew Chem Int Ed Engl. 2015. PMID: 25802144
[Standardized calculation in the pathology of urologic cancers].
de Fromont M, Lesourd A, Mazerolles C, Molinié V, Voigt JJ, Fromont G, Soulié M, Mottet N, Irani J, Méjean A, Rebillard X, Davin JL. de Fromont M, et al. Among authors: mazerolles c. Prog Urol. 2007 Nov;17(6):1026. doi: 10.1016/s1166-7087(07)74777-2. Prog Urol. 2007. PMID: 18153984 French. No abstract available.
[Standardized histopathology reports in urologic oncology].
de Fromont M, Lesourd A, Mazerolles C, Molinié V, Chasle J, Voigt JJ, Rébillard X, Davin JL. de Fromont M, et al. Among authors: mazerolles c. Prog Urol. 2004 Nov;14(4 Suppl 1):885-6. Prog Urol. 2004. PMID: 15779650 French. No abstract available.
Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
Rouprêt M, Seisen T, Compérat E, Larré S, Mazerolles C, Gobet F, Fetissof F, Fromont G, Safsaf A, d'Arcier BF, Celhay O, Validire P, Rozet F, Irani J, Soulié M, Pfister C; Comité de Cancérologie de l'Association Française d'Urologie. Rouprêt M, et al. Among authors: mazerolles c. J Urol. 2013 Jun;189(6):2069-76. doi: 10.1016/j.juro.2012.11.120. Epub 2012 Nov 28. J Urol. 2013. PMID: 23201497
85 results